首页 » P493-6 cell line人B细胞淋巴瘤系细胞株-BioVector NTCC保藏中心

P493-6 cell line人B细胞淋巴瘤系细胞株-BioVector NTCC保藏中心

  • 价  格:¥989865
  • 货  号:RRID:CVCL_6783
  • 产  地:北京
点击询问我要采购
 竭诚为您服务!
BioVector NTCC典型培养物保藏中心
联系人:Dr.Xu, Biovector NTCC Inc.

电话:400-800-2947 工作微信:1843439339 (QQ同号)

邮件:Biovector@163.com

手机:18901268599

地址:北京

已注册
 

Cell line:

P493-6

NTCC® no.:

SCC279

Species validation:

human (Homo sapiens)

Cell type:

B lymphoblastoid cells

Origin:

genetically modified cell line established in 1994 from the EBV-positive B-lymphoblastoid cell line ER/EB2-5 (NTCC®-ACC914) by stable transfection with plasmid pmyc-tet, which also encodes the transactivator protein tTA. MYC expression is observed in the absence of tetracycline and is repressed upon its addition.


Biosafety level:

2, GMO-S2

Risk assessment:

The cell line is positive for EBV (HHV-4) by PCR analysis. Additionally, expression of immediate-early protein BZLF-1 was detected by western blot after stimulating the cells with phorbol ester / sodium butyrate. The infection was classified as potentially lytic associated with a possible production of active viruses. A transmission of EBV during handling of the cells is possible and the cell line is thus categorized biosafety level 2 according to the German Biological Agents Regulation. Furthermore, the cells are genetically modified (EBNA2 expression inducible by estrogen and MYC expression suppressible by tetracyclin), which renders the cells in combination with the EBV infection biosafety level 2..


NTCC® Cell Culture Data:

Morphology:

mostly round cells growing in suspension;



Medium:

90% RPMI 1640 + 10% h.i. FBS + 2mM L-glutamine (expansion of the cell culture in the absence of tetracycline is recommended)

Subculture:

seed out 0.5 x 106 cells/ml; split 1:2 to 1:4 every 2-3 days

Incubation:

at 37 °C with 5% CO2

Doubling time:

about 36 hours

Harvest:

maximal density of ca. 1.5 x 10^6 cells/ml

Storage:

frozen with 70% medium, 20% FBS, 10% DMSO


NTCC® Scientific Data:

Mycoplasma:

negative in PCR assay

Immunology:

CD3 -, CD10 -, CD13 -, CD19 +, CD20 +, CD21 +, CD34 -, CD37 +, CD38 +, cy CD79a +, CD80 -, CD138 +, HLA-DR +, cy IgM +, cy IgG -, cy kappa +, cy lambda -;



Authenticity:

STR analysis according to the global standard ANSI/ATCC ASN-0002.1-2021 (2021) resulted in an authentic STR profile of the reference STR database, otherwise identical to parental cell line ER/EB2-5

Molec. Genetics:

MYC supression by tetracyclin (0.1 µg/ml, 72 h) was confirmed by Western blot analysis

Viruses:

PCR: EBV +, HBV -, HCV -, HIV-1 -, HIV-2 -, HTLV-1/2 -, MLV -


[Cell Designation细胞株名称] P493-6
[Organism物种来源] Homo sapiens
[Disease疾病种类]
[Cat Num编号] RRID:CVCL_6783
[Comments相关资料] Transfected with: HGNC; 7553; MYC. Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV). Omics: Cell surface proteome. DT Created: 04-04-12; Last updated: 07-09-18; Version: 8
培养方法:
完全培养基及血清:
贴壁/悬浮:
培养条件:

BioVector NTCC质粒载体菌种细胞蛋白抗体基因保藏中心
网址:www.biovector.net

您正在向 biovector.net  发送关于产品 P493-6 cell line人B细胞淋巴瘤系细胞株-BioVector NTCC保藏中心 的询问

点击“立即发送”后,我们将在1个工作日内与您取得联系。